Background
==========

First intention treatment for early acquired respiratory infections diagnosed in an ICU is usually made without micro--biological identification. Microbiological profile is important in supporting therapeutic options.

Objectives
==========

Study of the microbiological profile and effectiveness of first intention antibiotic therapy in early respiratory infections.

Methods
=======

Retrospective clinical study of 385 patients admitted to our ICU, from January to September 2000; selection of those with respiratory infection diagnosed in the first 72 hours of admission. **Tracheobronchitis** was defined by \'new\' purulent bronchial secretions, with fever (\> 38.5°C, axilar) and leucocytosis (\> 10,000), and **pneumonia** by the three mentioned criteria plus \'new\' pulmonary infiltrate. For these patients we reviewed the microbiologi--cal profile of specimens collected in the first 72 hours and the antimicrobial therapy.

Results
=======

In 105 (27.3%) of the patients admitted it was diagnosed an early respiratory infection: 47 (44.8%) had pneumonia and 58 had (55.2%) traqueobronquitis. A total of 56 organisms were isolated, in 43 patients (41%). 98.2% of the isolations were obtained from tracheobronchial aspiration. Agents involved were: *Haemophilus influenzae* (39.3%), *Staphylococcus aureus MS* (23.2%), *Streptoccus pneumoniae* (19.6%), *Klebsiella pneumoniae* (1.8%), *Moraxella catarrhalis* (1.8%), *E. coli* (3.6%), *Proteus mirabilis* (1.8%), *Enterobactereacea* (1.8%), *Pseudomonas aeruginosa* (3.6%), *Serratia marcenses* (1.8%) and *Staphylococcus aureus MR* (1.8%). The patients in whom we isolate the *Pseudomonas aeruginosa*, *Serratia marcenses* and *Staphylococcus aureus MR* were already hospitalised and had comorbidities. First intention treatment was in the vast majority amoxicilin + clavulanate (72 patients --- 68.6%). Initial therapy was changed according to antibiogram in 5 patients and in 18 patients (17.1%) it was necessary to change the therapy without microbiological guidance.

Conclusions
===========

Early respiratory infection is a frequent diagnosis in our ICU (27.3%). The microbiological profile in our patients shows, in 93% of the cases, organisms usually acquired in the community. Amoxicilin and clavulanate as first intention therapy appeared to be a good option (it failed only in 7% of the patients in whom it was used), and according to our microbiological profile it seems to be a good choice.
